1. Home
  2. DDI vs GKOS Comparison

DDI vs GKOS Comparison

Compare DDI & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DDI
  • GKOS
  • Stock Information
  • Founded
  • DDI 2008
  • GKOS 1998
  • Country
  • DDI South Korea
  • GKOS United States
  • Employees
  • DDI N/A
  • GKOS N/A
  • Industry
  • DDI EDP Services
  • GKOS Medical/Dental Instruments
  • Sector
  • DDI Technology
  • GKOS Health Care
  • Exchange
  • DDI Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • DDI 472.2M
  • GKOS 5.4B
  • IPO Year
  • DDI 2021
  • GKOS 2015
  • Fundamental
  • Price
  • DDI $9.27
  • GKOS $82.73
  • Analyst Decision
  • DDI Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • DDI 5
  • GKOS 12
  • Target Price
  • DDI $19.60
  • GKOS $128.58
  • AVG Volume (30 Days)
  • DDI 49.7K
  • GKOS 681.0K
  • Earning Date
  • DDI 11-10-2025
  • GKOS 11-03-2025
  • Dividend Yield
  • DDI N/A
  • GKOS N/A
  • EPS Growth
  • DDI N/A
  • GKOS N/A
  • EPS
  • DDI 2.15
  • GKOS N/A
  • Revenue
  • DDI $333,256,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • DDI $16.04
  • GKOS $28.79
  • Revenue Next Year
  • DDI $6.72
  • GKOS $25.65
  • P/E Ratio
  • DDI $4.32
  • GKOS N/A
  • Revenue Growth
  • DDI 0.24
  • GKOS 26.70
  • 52 Week Low
  • DDI $8.09
  • GKOS $77.10
  • 52 Week High
  • DDI $18.21
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • DDI 40.23
  • GKOS 33.60
  • Support Level
  • DDI $9.37
  • GKOS $86.81
  • Resistance Level
  • DDI $9.74
  • GKOS $95.32
  • Average True Range (ATR)
  • DDI 0.24
  • GKOS 2.79
  • MACD
  • DDI -0.02
  • GKOS -0.88
  • Stochastic Oscillator
  • DDI 4.40
  • GKOS 1.35

About DDI DoubleDown Interactive Co. Ltd. American Depository Shares

DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: